Cargando…

Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models

Galectin-1 is a hypoxia-regulated protein and a prognostic marker in head and neck squamous cell carcinomas (HNSCC). Here we assessed the ability of non-peptidic galectin-1 inhibitor OTX008 to improve tumor oxygenation levels via tumor vessel normalization as well as tumor growth inhibition in two h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koonce, Nathan A., Griffin, Robert J., Dings, Ruud P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751273/ https://www.ncbi.nlm.nih.gov/pubmed/29232825 http://dx.doi.org/10.3390/ijms18122671

Ejemplares similares

Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
por: Leung, Zoe, et al.
Publicado: (2019)

Effects of the Calix[4]arene Derivative Compound OTX008 on High Glucose-Stimulated ARPE-19 Cells: Focus on Galectin-1/TGF-β/EMT Pathway
por: Trotta, Maria Consiglia, et al.
Publicado: (2022)

Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia
por: Koonce, Nathan A., et al.
Publicado: (2015)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
por: Paz, Helicia, et al.
Publicado: (2018)

Simulating cellular galectin networks by mixing galectins in vitro reveals synergistic activity
por: Dings, Ruud P.M., et al.
Publicado: (2021)

Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas
por: Wang, Hannah, et al.
Publicado: (2017)

Isolation and analysis of tumor-derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin-based glycan recognition particles
por: Benecke, Laura, et al.
Publicado: (2022)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

Reduced Expression of Galectin-8 May Contribute in Carcinogenic Pathway of Head and Neck Squamous Cell Carcinoma
por: Ghasemi, Maryam, et al.
Publicado: (2021)

mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity
por: Patel, Jaimin, et al.
Publicado: (2020)

Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
por: Tran, Bao-Tram Thi, et al.
Publicado: (2022)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
por: Gong, Yingying, et al.
Publicado: (2023)

DNA methylation in tumor-adjacent normal tissue in the course of head and neck squamous cell carcinoma as an epigenetic field for cancerization
por: Strzelczyk, Joanna Katarzyna, et al.
Publicado: (2012)

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Burgener, Justin M., et al.
Publicado: (2021)

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
por: Kindt, Nadège, et al.
Publicado: (2017)

AB008. Activated pathways of Thymic Epithelial Tumors: a RYTHMIC study
por: Benitez, Jose Carlos, et al.
Publicado: (2022)

Tumor and Stromal-Based Contributions to Head and Neck Squamous Cell Carcinoma Invasion
por: Markwell, Steven M., et al.
Publicado: (2015)

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma
por: Backes, Clara, et al.
Publicado: (2017)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

Trending Speculations of Tumor-Initiating Cells in Squamous Cell Cancers of Head and Neck
por: Kamate, Wasim, et al.
Publicado: (2017)

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
por: Alfieri, Salvatore, et al.
Publicado: (2020)

Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma
por: Zhou, Shichao, et al.
Publicado: (2021)

The prognostic significance of tumor deposits in patients with head and neck squamous cell carcinomas
por: Yu, Shuting, et al.
Publicado: (2021)

TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell Carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
por: de Medeiros, Marcell Costa, et al.
Publicado: (2022)

Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
por: Qin, Yixiao, et al.
Publicado: (2021)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

Multimodal Dimension Reduction and Subtype Classification of Head and Neck Squamous Cell Tumors
por: Bard, Jonathan E., et al.
Publicado: (2022)

Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma
por: Kogo, Ryunosuke, et al.
Publicado: (2022)

The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
por: Zhang, Ye, et al.
Publicado: (2023)

OTX1 and OTX2 as Possible Molecular Markers of Sinonasal Carcinomas and Olfactory Neuroblastomas
por: Pirrone, Cristina, et al.
Publicado: (2017)

Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
por: Chikuie, Nobuyuki, et al.
Publicado: (2022)

Tumor vessel normalization and immunotherapy in gastric cancer
por: Yu, Xianzhe, et al.
Publicado: (2022)

The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2020)

SAT-008 Overcoming BCL-2 Resistance in Glucocorticoid-Treated Tumor Lymphoid Cells
por: Bortner, Carl, et al.
Publicado: (2019)

MON-LB008 PD-L1 Expression in Normal Endocrine Tissues
por: Pollack, Rena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r8v8c14tri8h1dt7nrd18ols1a